TradeLink Capital’s iShares Biotechnology ETF IBB Stock Holding History

TradeLink Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,600	Closed	-$2.04M	–	29
2018 Q2	$2.04M	Buy	+18,600	New	+$1.99M	9.82%	4
2017 Q3	–	Sell	-8,400	Closed	-$868K	–	12
2017 Q2	$868K	Buy	+8,400	New	+$827K	7.94%	2
2015 Q4	–	Sell	-10,503	Closed	-$1.06M	–	127
2015 Q3	$1.06M	Buy	+10,503	New	+$1.26M	2.63%	7
2014 Q3	–	Sell	-3,600	Closed	-$308K	–	295
2014 Q2	$308K	Buy	+3,600	New	+$284K	0.28%	72

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TradeLink Capital's IBB Position: Q3 2018 in Review

TradeLink Capital sold out of iShares Biotechnology ETF (IBB) in Q3 2018, closing a stake of 18,600 shares — an estimated $2.04M sold.

TradeLink Capital first reported a position in IBB in Q2 2014 and held it in 4 quarters. The position peaked at $2.04M in Q2 2018. 631 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

TradeLink Capital reported no remaining iShares Biotechnology ETF position as of Q3 2018 after selling out during the quarter.
TradeLink Capital sold 18,600 iShares Biotechnology ETF shares in Q3 2018, an estimated $2.04M.
TradeLink Capital first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 4 quarters.
TradeLink Capital's iShares Biotechnology ETF position peaked at $2.04M in Q2 2018.
631 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on TradeLink Capital's 13F filing for Q3 2018, filed 5 Nov 2018.